• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《MJA 实践要点——内分泌学》。第 9 章:成人垂体疾病

MJA Practice Essentials--Endocrinology. 9: Pituitary disease in adults.

作者信息

Hurley David M, Ho Ken K Y

机构信息

Department of Endocrinology and Diabetes, Royal Perth Hospital, Wellington Street Campus, Box X2213, GPO, Perth, WA 6847, Australia.

出版信息

Med J Aust. 2004 Apr 19;180(8):419-25.

PMID:15089738
Abstract

Pituitary adenomas are found in 10%-25% of unselected autopsy series and are evident in about 10% of asymptomatic individuals by magnetic resonance imaging. Diagnosis of pituitary disorders is often delayed by lack of awareness and the subtlety of symptoms and signs. Hypopituitarism is suspected when peripheral hormone concentrations are low without an elevation in the corresponding pituitary tropic hormone(s). Severe adult-onset growth-hormone deficiency results in reduced muscle mass, increased fat mass and diminished quality of life, which are reversed by growth hormone replacement therapy. While trans-sphenoidal surgery remains first-line treatment for acromegaly, drug treatment has an important role in controlling residual growth-hormone excess and, in some circumstances, as first-line treatment. Dopamine-agonist therapy (cabergoline or bromocriptine) is the treatment of choice for micro- and macroprolactinomas. In patients with suggestive clinical features, elevated 24-hour urine free cortisol level is usually sufficient to diagnose endogenous Cushing's syndrome; careful additional investigation is needed to determine whether the cause is Cushing's disease (pituitary adenoma secreting adrenocorticotropic hormone [ACTH]), ectopic ACTH secretion or adrenal disease. Heightened awareness is needed to detect the sometimes subtle symptoms and signs of pituitary disease

摘要

在未经筛选的尸检系列中,垂体腺瘤的发现率为10% - 25%,在约10%的无症状个体中,磁共振成像可显示垂体腺瘤。由于缺乏认识以及症状和体征不明显,垂体疾病的诊断常常被延误。当外周激素浓度较低而相应的垂体促激素没有升高时,怀疑存在垂体功能减退。严重的成人起病型生长激素缺乏会导致肌肉量减少、脂肪量增加和生活质量下降,而生长激素替代疗法可逆转这些情况。虽然经蝶窦手术仍然是肢端肥大症的一线治疗方法,但药物治疗在控制残余的生长激素过多方面具有重要作用,在某些情况下也可作为一线治疗。多巴胺激动剂疗法(卡麦角林或溴隐亭)是微泌乳素瘤和大泌乳素瘤的首选治疗方法。对于具有提示性临床特征的患者,24小时尿游离皮质醇水平升高通常足以诊断内源性库欣综合征;需要进行仔细的进一步检查以确定病因是库欣病(分泌促肾上腺皮质激素[ACTH]的垂体腺瘤)、异位ACTH分泌还是肾上腺疾病。需要提高认识以检测垂体疾病有时不明显的症状和体征。

相似文献

1
MJA Practice Essentials--Endocrinology. 9: Pituitary disease in adults.《MJA 实践要点——内分泌学》。第 9 章:成人垂体疾病
Med J Aust. 2004 Apr 19;180(8):419-25.
2
[Cycle disorders, polydipsia, decline of vision. Is it the fault of the hypophysis?].[周期紊乱、烦渴、视力下降。这是垂体的问题吗?]
MMW Fortschr Med. 2001 Nov 1;143(44):28-30, 32-4.
3
[New developments in pituitary diseases].[垂体疾病的新进展]
Dtsch Med Wochenschr. 2012 Dec;137(49):2540-2. doi: 10.1055/s-0032-1327285. Epub 2012 Nov 27.
4
First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial.一线长效奥曲肽治疗可使肢端肥大症患者肿瘤缩小并控制激素过量:一项开放、前瞻性、多中心试验的结果
Clin Endocrinol (Oxf). 2006 Mar;64(3):342-51. doi: 10.1111/j.1365-2265.2006.02467.x.
5
[Clinical neuroendocrinology].[临床神经内分泌学]
Sb Lek. 1995;96(4):333-8.
6
Surgical management of pituitary adenomas.垂体腺瘤的外科治疗
Singapore Med J. 2002 Jun;43(6):318-23.
7
[The treatment of acromegaly].[肢端肥大症的治疗]
Union Med Can. 1993 Nov-Dec;122(6):489-95.
8
Evaluation and treatment of Cushing's syndrome.库欣综合征的评估与治疗。
Am J Med. 2005 Dec;118(12):1340-6. doi: 10.1016/j.amjmed.2005.01.059.
9
Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.肢端肥大症的术前奥曲肽治疗:最终生长激素(GH)浓度和垂体功能无改善。一项长期病例对照研究。
Acta Neurochir (Wien). 2005 May;147(5):485-93; discussion 493. doi: 10.1007/s00701-005-0511-9. Epub 2005 Apr 4.
10
Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue?对于先前对生长抑素类似物耐药的肢端肥大症患者,手术部分切除肿瘤是否会影响其对长效奥曲肽的反应?
Clin Endocrinol (Oxf). 2007 Aug;67(2):310-5. doi: 10.1111/j.1365-2265.2007.02885.x. Epub 2007 Jun 6.

引用本文的文献

1
MicroRNAs as Potential Biomarkers in Pituitary Adenomas.微小RNA作为垂体腺瘤潜在的生物标志物
Noncoding RNA. 2021 Sep 3;7(3):55. doi: 10.3390/ncrna7030055.
2
Anesthesia and Intensive care implications for pituitary surgery: Recent trends and advancements.垂体手术的麻醉与重症监护意义:近期趋势与进展
Indian J Endocrinol Metab. 2011 Sep;15 Suppl 3(Suppl3):S224-32. doi: 10.4103/2230-8210.84872.
3
Pituitary incidentalomas--how often is too often?垂体偶发瘤——多频繁才算过于频繁?
J Med Life. 2009 Jan-Mar;2(1):92-7.
4
Mandibular prognathism caused by acromegaly - a surgical orthodontic case.肢端肥大症所致下颌前突——一例外科正畸病例
Head Face Med. 2009 Aug 6;5:16. doi: 10.1186/1746-160X-5-16.
5
Inter- and intra-observer variability in detection and progression assessment with MRI of microadenoma in Cushing's disease patients followed up after bilateral adrenalectomy.
Pituitary. 2008;11(3):263-9. doi: 10.1007/s11102-008-0123-5.